Alvogen Recalls Fentanyl Transdermal System Lot Over Delivery System Defect Alvogen has initiated a voluntary nationwide recall of a specific lot of its Fentanyl Transdermal System due to a potentially defective delivery system. Users are advised to take immediate action.

Alvogen Recalls Fentanyl Transdermal System Lot Over Delivery System Defect #United_States #Drug_Safety #Morristown #Alvogen #Fentanyl_Recall